Needham & Company Reiterates a 'Buy' on Gilead Sciences (GILD); Q2 Beats; Management Maps Out Phase 3 GS-7977 Plans

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. KEYS
2. MRNA
3. KLAR
4. PANW
5. HD
6. DVLT
7. MRK
8. PGR
9. EPM
10. MRCY

Go back to Needham & Company Reiterates a 'Buy' on Gilead Sciences (GILD); Q2 Beats; Management Maps Out Phase 3 GS-7977 Plans
Gilead Sciences (NASDAQ: GILD) Delayed: 148.09 +4.65 (3.24%)
Previous Close $143.44    52 Week High $108.63 
Open $145.10    52 Week Low $71.39 
Day High $148.97    P/E 81.82 
Day Low $144.30    EPS $1.81 
Volume 3,412,603